A drug screen in this model identified 12 neuroprotective compounds, two of which (ALS-approved drugs riluzole and nifedipine) also rescue motor deficits in a C. elegans model of TDP-43 toxicity (Ikenaka et al., 2019). Here, TARDBP is linked to amyotrophic lateral sclerosis.